Abstract
To develop a new radiosensitizer against non-small cell lung cancer cells, we screened a natural product library for growth-inhibitory compounds. PA was found to be cytotoxic toward NCI-H460 cells, and its IC₅₀ value was determined. The radiosensitizer effects of PA were tested at its IC₅₀ value in clonogenic and cell-counting assays. The intracellular mechanism underlying this effect was determined by immunoblotting and by measuring propidium iodide uptake and ROS generation. The radiosensitizer activity of PA in vivo was tested in nude mice by treating with PA and IR, and measuring tumor volume and assessing apoptosis. PA, tested at its experimentally determined IC₅₀ value (12 nM), enhanced IR-induced death of NCI-H460 cells by increasing apoptosis, yielding a mean calculated dose-enhancement ratio of 1.67. Combination with PA and IR also increased the production of ROS, which subsequently induced phosphorylation of p38, suppressed phosphorylation of ERK, and activated caspase-3, -8, and -9. Notably, inhibition of ROS production prevented p38 phosphorylation, and inhibition of ROS production or p38 activation blocked caspase activation and apoptosis. In a xenograft assay, combination with PA and IR delayed tumor growth by 11....Continue Reading
References
Dec 18, 1998·Journal of Neuroscience Research·M D JohnsonR S Morrison
May 8, 2001·International Journal of Cancer. Journal International Du Cancer·I V FilippovichJ F Chatal
Mar 16, 2002·The Cancer Journal·Vinay K GuptaRalph R Weichselbaum
Apr 12, 2003·FEBS Letters·Zerihun AssefaPatrizia Agostinis
Apr 23, 2004·Trends in Molecular Medicine·James M Olson, Andrew R Hallahan
Aug 11, 2004·Toxicon : Official Journal of the International Society on Toxinology·M GordalizaM A Gómez-Zurita
Dec 16, 2005·Clinical Lung Cancer·Alex A Adjei
Jan 18, 2006·The Journal of Biological Chemistry·Soon-Young ChoiSu-Jae Lee
Oct 7, 2006·Free Radical Biology & Medicine·An Van LaethemPatrizia Agostinis
Jun 15, 2007·Toxicologic Pathology·Susan Elmore
Feb 12, 2008·Cellular Signalling·Eun Mi KimHong-Duck Um
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Apr 1, 2008·International Journal of Radiation Oncology, Biology, Physics·Jong Kuk ParkSung Hee Hong
May 29, 2008·Journal of the National Cancer Institute·Brian D LawendaJeffrey B Blumberg
Mar 3, 2009·International Journal of Radiation Oncology, Biology, Physics·David KatzFei-Fei Liu
Jul 25, 2009·Nature Reviews. Cancer·Erwin F Wagner, Angel R Nebreda
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Mar 25, 2011·Nature Reviews. Cancer·Adrian C BeggConchita Vens
Mar 27, 2012·Expert Opinion on Therapeutic Targets·Antonella De LucaNicola Normanno
Feb 27, 2013·Nature Reviews. Clinical Oncology·Tetsuya MitsudomiYasushi Yatabe
Dec 19, 2013·Genes & Cancer·Anupama Munshi, Rajagopal Ramesh
Citations
Jun 11, 2015·Free Radical Research·Y YoshikawaQ-M Zhang-Akiyama
Jun 13, 2015·Drug Delivery·Yuhui ChenLingjing Jin
Sep 1, 2015·International Journal of Oncology·Jae Yeon ChoiJong Kuk Park
Dec 17, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jeong Hyun ChoJong Kuk Park
Dec 19, 2015·Oxidative Medicine and Cellular Longevity·Ya-Qin HouYu-Xin Li
Mar 25, 2017·Renal Failure·Lei YuRuihua An
Dec 5, 2018·Reviews on Environmental Health·Lei Jiang, Hitoshi Iwahashi
Jan 27, 2018·Oncotarget·Wan Gi HongJong Kuk Park
Sep 8, 2020·Free Radical Research·Tingyi Zhao, Qiu-Mei Zhang-Akiyama
Apr 2, 2016·International Journal of Oncology·Wan Gi HongJong Kuk Park
Jun 20, 2019·Toxins·Ya-Li WangLin Feng
Mar 2, 2017·Scientific Reports·XiaoHong YangXiaoHong Chen
Mar 9, 2019·Journal of Bioenergetics and Biomembranes·Seyed Jalal HosseinimehrHossein Asgarian-Omran
Dec 15, 2020·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·R Pascual-SerraR Sánchez-Prieto
Aug 28, 2021·Frontiers in Cell and Developmental Biology·Hua-Yang FanXin-Hua Liang